Patient-Reported Quality of Life at Diagnosis in Adolescent and Young Adults With Cancer
- PMID: 38996438
- PMCID: PMC11684396
- DOI: 10.6004/jnccn.2024.7012
Patient-Reported Quality of Life at Diagnosis in Adolescent and Young Adults With Cancer
Abstract
Background: The overall landscape of health-related quality of life (HRQoL) has not been thoroughly investigated in adolescents and young adults (AYAs) with cancer. Data are also lacking on how well HRQoL at the time of cancer diagnosis can prognosticate long-term survival in AYA survivors.
Patients and methods: We included 3,497 survivors of AYA cancer (age 15-39 years at diagnosis) who completed the Short-Form 12 Health Survey (SF-12) HRQoL questionnaire at diagnosis. Physical component summary (PCS) and mental component summary (MCS) scores were generated, with scores <50 representing poor HRQoL. Differences in HRQoL by patient characteristics and tumor type were investigated using violin plots and t tests/analysis of variance. The effect of HRQoL on overall survival was assessed using Kaplan-Meier plots and Cox proportional hazards models.
Results: Overall mean PCS and MCS scores in this racially/ethnically diverse cohort (64% White, 19% Hispanic, 10% Black, and 7% other race/ethnicity) were 43.6 and 46.7, respectively. Women with breast cancer reported the most favorable PCS (50.8), and those with cervical cancer reported the lowest MCS (42.8). Age at diagnosis was associated positively with PCS (P<.001) and inversely with MCS (P<.001). Females had higher PCS yet lower MCS than males (both P<.001). Marginalized racial and ethnic populations reported lower PCS than White patients (P<.001). Physical and mental HRQoL were prognostic and associated with increased risk of poor survival (hazard ratio, 1.95; 95% CI, 1.72-2.21 for physical HRQoL, and 1.26; 95% CI, 1.13-1.40 for mental HRQoL).
Conclusions: Physical and mental HRQoL at diagnosis vary across patient characteristics in AYA cancer survivors. Poor HRQoL at diagnosis may be a prognosticator of diminished overall survival among AYA cancer survivors.
Conflict of interest statement
CONFLICTS OF INTEREST
The authors declare no conflicts of interest.
Figures



Similar articles
-
Racial/ethnic differences in health-related quality of life among female breast cancer survivors: cross-sectional findings from the Medical Expenditure Panel Survey.Public Health. 2021 Jul;196:74-81. doi: 10.1016/j.puhe.2021.05.021. Epub 2021 Jun 20. Public Health. 2021. PMID: 34161858
-
Lifestyle factors and health-related quality of life in adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study.Cancer. 2018 Oct 1;124(19):3918-3923. doi: 10.1002/cncr.31647. Epub 2018 Sep 11. Cancer. 2018. PMID: 30204245 Free PMC article.
-
Health-related quality of life in adolescent and young adult cancer survivors.Support Care Cancer. 2018 Sep;26(9):3099-3110. doi: 10.1007/s00520-018-4151-z. Epub 2018 Mar 23. Support Care Cancer. 2018. PMID: 29572734
-
Trends in racial and ethnic disparities in health-related quality of life in older adults with lung cancer.J Geriatr Oncol. 2024 Nov;15(8):102066. doi: 10.1016/j.jgo.2024.102066. Epub 2024 Sep 12. J Geriatr Oncol. 2024. PMID: 39270427
-
Relationship between patient-reported health-related quality of life as measured with the SF-36 or SF-12 and their mortality risk in patients with diverse cancer type: a meta-analysis.Int J Clin Oncol. 2025 Feb;30(2):252-266. doi: 10.1007/s10147-024-02659-0. Epub 2024 Nov 22. Int J Clin Oncol. 2025. PMID: 39578317
References
-
- Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2018. In: National Cancer Insitute, Bethesda, MD; 2021.
-
- Bleyer A, Barr R, Hayes-Lattin B, et al. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer 2008;8(4):288–98. - PubMed
-
- Barr RD, Ferrari A, Ries L, et al. Cancer in Adolescents and Young Adults: A Narrative Review of the Current Status and a View of the Future. JAMA Pediatr 2016;170(5):495–501. - PubMed
-
- Sender L, Zabokrtsky KB. Adolescent and young adult patients with cancer: a milieu of unique features. Nat Rev Clin Oncol 2015;12(8):465–80. - PubMed
-
- Core Patient-Reported Outcomes in Cancer Clinical Trials: Draft Guidance for Industry. In: Excellence OCo, Research CfBEa, Research CfDEa, (eds); 2021.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical